Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:41 pm Purchase | 2024-12-31 | 13G | IN8bio, Inc. INAB | William Tai-Wei Ho | 4,098,800 5.600% | 972,295 (+31.10%) | Filing History |
| 2025-02-14 4:29 pm Purchase | 2024-12-31 | 13G | IN8bio, Inc. INAB | Alyeska Investment Group, L.P. | 7,241,076 9.900% | 7,241,076 (New Position) | Filing History |
| 2025-01-31 4:05 pm Sale | 2024-12-31 | 13G | IN8bio, Inc. INAB | Orin Hirschman | 6,191,865 8.500% | -546,067 (-8.10%) | Filing History |
| 2024-10-11 6:01 pm Unchanged | 2024-10-04 | 13D | IN8bio, Inc. INAB | BIOS Fund II LP | 10,416,165 23.100% | 0 (Unchanged) | Filing History |
| 2024-10-09 5:19 pm Purchase | 2024-10-01 | 13G | IN8bio, Inc. INAB | Orin Hirschman | 6,737,932 9.300% | 4,403,264 (+188.60%) | Filing History |
| 2024-09-17 7:30 pm Sale | 2024-06-14 | 13G | IN8bio, Inc. INAB | Orin Hirschman | 2,334,668 4.990% | -1,763,693 (-43.03%) | Filing History |
| 2024-02-13 4:04 pm Purchase | 2023-12-31 | 13G | IN8bio, Inc. INAB | William Tai-Wei Ho | 3,126,505 7.100% | 225,606 (+7.78%) | Filing History |
| 2023-12-15 4:31 pm Sale | 2023-12-13 | 13G | IN8bio, Inc. INAB | Transcend Partners Opportunity Fund I LLC | 3,222,485 7.500% | -889,473 (-21.63%) | Filing History |
| 2023-12-15 06:26 am Purchase | 2023-12-11 | 13G | IN8bio, Inc. INAB | Orin Hirschman | 4,098,361 9.400% | 4,098,361 (New Position) | Filing History |
| 2023-12-15 06:08 am Purchase | 2023-12-13 | 13D | IN8bio, Inc. INAB | BIOS Fund II LP | 10,416,165 23.100% | 3,778,288 (+56.92%) | Filing History |
| 2023-08-11 4:28 pm Purchase | 2021-12-31 | 13G | IN8bio, Inc. INAB | William Tai-Wei Ho | 2,900,899 9.100% | 2,900,899 (New Position) | Filing History |
| 2023-08-11 4:18 pm Purchase | 2021-08-03 | 13G | IN8bio, Inc. INAB | Transcend Partners Opportunity Fund I LLC | 4,111,958 13.000% | 4,111,958 (New Position) | Filing History |
| 2021-08-13 4:16 pm Purchase | 2021-08-03 | 13D | IN8bio, Inc. INAB | BIOS Fund II LP | 6,637,877 35.400% | 6,637,877 (New Position) | Filing History |